Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine, magnesium sulfate, and fentanyl as epidural adjuvants to bupivacaine after abdominal surgery
PACTR202509471921862Phase 3Unknown
- Sponsor
- Al-Azhar University
- Start
- Mar 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bupivacaine, dexmedetomidine, magnesium sulfate and fentanyl in postoperative pain (4 arms), sponsored by Al-Azhar University. Primary endpoint: duration of analgesia. Status: unknown.
02
Drugs
bupivacainedexmedetomidinemagnesium sulfatefentanyl
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202509471921862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202509471921862.